Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Name: Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)
Published: 2025
License: Public Domain

First Affiliated Hospital of Zhejiang University · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

acute-myeloid-leukemia

acute myeloid leukemia, high-risk acute myeloid leukemia, myelodysplastic syndromes, high-risk myelodysplastic syndromes, venetoclax, bucy conditioning, allogeneic hematopoietic stem cell transplantation, myeloablative conditioning, relapse-free survival, graft-versus-leukemia, gvhd, high-risk aml

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 903914
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.